Propeller Health

GSK's Ellipta inhaler GlaxoSmithKline and Madison, Wisconsin-based Propeller Health announced a partnership today in which Propeller will develop and manufacture a custom sensor for GSK's Ellipta inhaler for COPD patients.

Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way.

Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim.

A screenshot from Share the Journey.

Madison, Wisconsin-based Propeller Health is expanding its collaboration with the City of Louisville, Kentucky, thanks to a grant from the Robert Wood Johnson Foundation.

Boehringer Ingelheim is a pretty familiar name to people who follow mobile health moves from pharma companies.

Madison, Wisconsin-based Propeller Health, formerly known as Asthmapolis, has raised $14.

New Zealand-based medical device company Nexus6 has received FDA clearance for its smartphone-connected inhaler, SmartTouch, as a class II medical device.